OIG releases reports on drug pricing and Nebraska cost claims
Compliance Monitor, June 7, 2006
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Some government requirements for determining the average manufacturer price (AMP) for prescription drugs are not clear and comprehensive, according to the OIG.
The OIG has further found that manufacturers' methods for calculating AMPs are not consistent.
Click here to read the report "Determining Average Manufacturers Prices for Prescription Drugs Under the Deficit Reduction Act of 2005" (A-06-06-00063).
In other news, the OIG has also released an audit showing that Nebraska did not properly claim payments for skilled professional medical personnel, and recommends the state refund $292,903.
Specifically, the state claimed costs for personnel who did not meet education requirements or who were in positions that did not require medical expertise.
Click here to read the report "Nebraska Medicaid Payments for Skilled Professional Medical Personnel" (A-07-05-03067).
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- CMS has reformulated payments for some bilateral procedures
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- ED-to-inpatient transfers are flawed with safety gaps
- Searched
